These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 11313917)

  • 61. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
    Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
    Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Myc and Max proteins possess distinct transcriptional activities.
    Kretzner L; Blackwood EM; Eisenman RN
    Nature; 1992 Oct; 359(6394):426-9. PubMed ID: 1406956
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cell-cycle progression is not essential for c-Myc to block differentiation.
    Ryan KM; Birnie GD
    Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activation of gene transcription by the amino terminus of the N-Myc protein does not require association with the protein encoded by the retinoblastoma suppressor gene RB1.
    Cziepluch C; Wenzel A; Schürmann J; Schwab M
    Oncogene; 1993 Oct; 8(10):2833-8. PubMed ID: 8378092
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression and subcellular localization of the Myc superfamily proteins: c-Myc, Max, Mad1 and Mxi1 in the epiphyseal plate cartilage chondrocytes of growing rats.
    Wang Y; Toury R; Hauchecorne M; Balmain N
    Cell Mol Biol (Noisy-le-grand); 1997 Mar; 43(2):175-88. PubMed ID: 9130602
    [TBL] [Abstract][Full Text] [Related]  

  • 66. c-Myc and Max interactions in quiescent and mitogen-stimulated primary hepatocytes.
    Skouteris GG; Schröder CH
    Exp Cell Res; 1996 Jun; 225(2):237-44. PubMed ID: 8660911
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.
    Hagiyama H; Adachi T; Yoshida T; Nomura T; Miyasaka N; Honjo T; Tsubata T
    Oncogene; 1999 Jul; 18(28):4091-8. PubMed ID: 10435590
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Highly controlled heterologous gene expression through combined utilization of the tetracycline-repressible transactivator and the lac repressor.
    Hoshikawa Y; Amimoto K; Mizuguchi R; Hatakeyama M
    Anal Biochem; 1998 Aug; 261(2):211-8. PubMed ID: 9716424
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
    Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cloning and functional expression of a degradation-resistant novel isoform of p27Kip1.
    Hirano K; Hirano M; Zeng Y; Nishimura J; Hara K; Muta K; Nawata H; Kanaide H
    Biochem J; 2001 Jan; 353(Pt 1):51-57. PubMed ID: 11115398
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Life and death decisions in B1 lymphoma cells.
    Donjerković D; Carey GB; Mueller CM; Liu S; Scott DW
    Curr Top Microbiol Immunol; 2000; 252():151-9. PubMed ID: 11187083
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes.
    Wahlström T; Belikov S; Arsenian Henriksson M
    Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest.
    Jeong KC; Ahn KO; Yang CH
    Mol Biosyst; 2010 Aug; 6(8):1503-9. PubMed ID: 20485733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CREBL2, a novel transcript from the chromosome 12 region flanked by ETV6 and CDKN1B.
    Hoornaert I; Marynen P; Baens M
    Genomics; 1998 Jul; 51(1):154-7. PubMed ID: 9693048
    [No Abstract]   [Full Text] [Related]  

  • 75. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
    Min S; Mascarenhas NT; Taparowsky EJ
    Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights.
    Facchini LM; Penn LZ
    FASEB J; 1998 Jun; 12(9):633-51. PubMed ID: 9619443
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Minimal requirements for the nuclear localization of p27(Kip1), a cyclin-dependent kinase inhibitor.
    Zeng Y; Hirano K; Hirano M; Nishimura J; Kanaide H
    Biochem Biophys Res Commun; 2000 Jul; 274(1):37-42. PubMed ID: 10903892
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of myc amplification and overexpression in cell growth, differentiation and death.
    Koskinen PJ; Alitalo K
    Semin Cancer Biol; 1993 Feb; 4(1):3-12. PubMed ID: 8448376
    [TBL] [Abstract][Full Text] [Related]  

  • 79. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
    Reisman D; Elkind NB; Roy B; Beamon J; Rotter V
    Cell Growth Differ; 1993 Feb; 4(2):57-65. PubMed ID: 8494784
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inducible expression of Mad accelerates growth arrest of serum deprived human glioblastoma cells.
    Roy B; Reisman D
    Cell Biol Int; 1995 Apr; 19(4):307-13. PubMed ID: 7613518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.